chrX-155081874-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001018055.3(BRCC3):c.403+3171G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000806 in 111,643 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.000081 ( 0 hom., 2 hem., cov: 23)
Consequence
BRCC3
NM_001018055.3 intron
NM_001018055.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.03
Genes affected
BRCC3 (HGNC:24185): (BRCA1/BRCA2-containing complex subunit 3) This gene encodes a subunit of the BRCA1-BRCA2-containing complex (BRCC), which is an E3 ubiquitin ligase. This complex plays a role in the DNA damage response, where it is responsible for the stable accumulation of BRCA1 at DNA break sites. The component encoded by this gene can specifically cleave Lys 63-linked polyubiquitin chains, and it regulates the abundance of these polyubiquitin chains in chromatin. The loss of this gene results in abnormal angiogenesis and is associated with syndromic moyamoya, a cerebrovascular angiopathy. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, Jun 2011]
MTCP1 (HGNC:7423): (mature T cell proliferation 1) This gene was identified by involvement in some t(X;14) translocations associated with mature T-cell proliferations. This region has a complex gene structure, with a common promoter and 5' exon spliced to two different sets of 3' exons that encode two different proteins. This gene represents the upstream 13 kDa protein that is a member of the TCL1 family. This protein may be involved in leukemogenesis. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-155081874-G-A is Benign according to our data. Variant chrX-155081874-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 223599.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRCC3 | NM_001018055.3 | c.403+3171G>A | intron_variant | ENST00000330045.12 | NP_001018065.1 | |||
BRCC3 | NM_001242640.2 | c.406+3171G>A | intron_variant | NP_001229569.1 | ||||
BRCC3 | NM_024332.4 | c.403+3171G>A | intron_variant | NP_077308.1 | ||||
BRCC3 | XM_005274751.5 | c.406+3171G>A | intron_variant | XP_005274808.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRCC3 | ENST00000330045.12 | c.403+3171G>A | intron_variant | 1 | NM_001018055.3 | ENSP00000328641 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000807 AC: 9AN: 111590Hom.: 0 Cov.: 23 AF XY: 0.0000592 AC XY: 2AN XY: 33760
GnomAD3 genomes
AF:
AC:
9
AN:
111590
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33760
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0000806 AC: 9AN: 111643Hom.: 0 Cov.: 23 AF XY: 0.0000591 AC XY: 2AN XY: 33823
GnomAD4 genome
AF:
AC:
9
AN:
111643
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33823
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, no assertion criteria provided | clinical testing | University of Washington Department of Laboratory Medicine, University of Washington | Dec 01, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at